The FDA determined the tirzepatide shortage resolved in late 2024 and removed semaglutide from its shortage list in February 2025, then set wind-down deadlines after which large-scale compounding of essentially-a-copy of these drugs was no longer permitted (FDA)
Do they worsen after a high-carb meal
Tacha D, Qi W, Ra S, Bremer R, Yu C, Chu J, et al
Methemoglobinemia: This is a blood disorder characterized by higher than normal levels of methemoglobin, reducing the blood's ability to carry oxygen
The first, led by Professor Carmen Scheibenbogen (Institute of Medical Immunology, Charit), investigates whether semaglutidea GLP-1 receptor agonistcan improve symptoms and quality of life for people with ME/CFS who are receiving treatment for being overweight
(3) Studies with insufficient methodological detail or irrelevant outcomes (e.g., isolated heat stress without liver injury assessment)